ENDRA Non Current Liabilities Total from 2010 to 2024

NDRA Stock  USD 5.09  0.18  3.42%   
ENDRA Life's Non Current Liabilities Total is increasing over the years with slightly volatile fluctuation. Overall, Non Current Liabilities Total is expected to go to about 251.3 K this year. From 2010 to 2024 ENDRA Life Non Current Liabilities Total quarterly data regression line had arithmetic mean of  153,851 and r-squared of  0.48. View All Fundamentals
 
Non Current Liabilities Total  
First Reported
2015-12-31
Previous Quarter
98.4 K
Current Value
M
Quarterly Volatility
277.5 K
 
Yuan Drop
 
Covid
Check ENDRA Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ENDRA Life's main balance sheet or income statement drivers, such as Depreciation And Amortization of 772.7 K, Interest Expense of 23.5 K or Selling General Administrative of 3.7 M, as well as many indicators such as Price To Sales Ratio of 1.8 M, Dividend Yield of 0.0 or PTB Ratio of 5.6 K. ENDRA financial statements analysis is a perfect complement when working with ENDRA Life Valuation or Volatility modules.
  
Check out the analysis of ENDRA Life Correlation against competitors.

Latest ENDRA Life's Non Current Liabilities Total Growth Pattern

Below is the plot of the Non Current Liabilities Total of ENDRA Life Sciences over the last few years. It is ENDRA Life's Non Current Liabilities Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ENDRA Life's overall financial position and show how it may be relating to other accounts over time.
Non Current Liabilities Total10 Years Trend
Slightly volatile
   Non Current Liabilities Total   
       Timeline  

ENDRA Non Current Liabilities Total Regression Statistics

Arithmetic Mean153,851
Geometric Mean0.00
Coefficient Of Variation141.78
Mean Deviation184,620
Median1.00
Standard Deviation218,125
Sample Variance47.6B
Range609K
R-Value0.69
Mean Square Error26.8B
R-Squared0.48
Significance0
Slope33,716
Total Sum of Squares666.1B

ENDRA Non Current Liabilities Total History

2024251.3 K
2023192.1 K
2022365.9 K
2021546.6 K
2020609 K
2019342.8 K

About ENDRA Life Financial Statements

ENDRA Life stakeholders use historical fundamental indicators, such as ENDRA Life's Non Current Liabilities Total, to determine how well the company is positioned to perform in the future. Although ENDRA Life investors may analyze each financial statement separately, they are all interrelated. For example, changes in ENDRA Life's assets and liabilities are reflected in the revenues and expenses on ENDRA Life's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in ENDRA Life Sciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Non Current Liabilities Total192.1 K251.3 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether ENDRA Life Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ENDRA Life's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Endra Life Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Endra Life Sciences Stock:
Check out the analysis of ENDRA Life Correlation against competitors.
You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ENDRA Life. If investors know ENDRA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ENDRA Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
-3 K
Return On Assets
(0.61)
Return On Equity
(1.20)
The market value of ENDRA Life Sciences is measured differently than its book value, which is the value of ENDRA that is recorded on the company's balance sheet. Investors also form their own opinion of ENDRA Life's value that differs from its market value or its book value, called intrinsic value, which is ENDRA Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ENDRA Life's market value can be influenced by many factors that don't directly affect ENDRA Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ENDRA Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if ENDRA Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ENDRA Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.